Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®).
Saved in:
| Title: | Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®). |
|---|---|
| Authors: | Douez E; UPR 4301 CBM, CNRS, NMNS department, University of Tours, F-37200 Tours, France; Pharmacy Department, Tours University Hospital, F-37200, France. Electronic address: emmanuel.douez@univ-tours.fr., Joubert N; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France., Gabant G; UPR 4301 CBM, CNRS, MO2VING platform, University of Orleans, 45100 Tours, France., Vidy E; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France., Auvert E; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France., Boursin F; UMR 1282 ISP, Team BioMAP, University of Tours - INRAE, F-37200 Tours, France., Dupeyrol G; UMR 1282 ISP, Team BioMAP, University of Tours - INRAE, F-37200 Tours, France., André V; Pharmacy Department, Tours University Hospital, F-37200, France., Velge Roussel F; UPR 4301 CBM, CNRS, NMNS department, University of Tours, F-37200 Tours, France., Denevault-Sabourin C; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France., Aubrey N; UMR 1282 ISP, Team BioMAP, University of Tours - INRAE, F-37200 Tours, France., Allard-Vannier E; UPR 4301 CBM, CNRS, NMNS department, University of Tours, F-37200 Tours, France. |
| Source: | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2026 Jun 01; Vol. 221, pp. 107536. Date of Electronic Publication: 2026 Apr 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 9317982 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0720 (Electronic) Linking ISSN: 09280987 NLM ISO Abbreviation: Eur J Pharm Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42009233 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Douez+E%22">Douez E</searchLink>; UPR 4301 CBM, CNRS, NMNS department, University of Tours, F-37200 Tours, France; Pharmacy Department, Tours University Hospital, F-37200, France. Electronic address: emmanuel.douez@univ-tours.fr.<br /><searchLink fieldCode="AU" term="%22Joubert+N%22">Joubert N</searchLink>; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France.<br /><searchLink fieldCode="AU" term="%22Gabant+G%22">Gabant G</searchLink>; UPR 4301 CBM, CNRS, MO2VING platform, University of Orleans, 45100 Tours, France.<br /><searchLink fieldCode="AU" term="%22Vidy+E%22">Vidy E</searchLink>; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France.<br /><searchLink fieldCode="AU" term="%22Auvert+E%22">Auvert E</searchLink>; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France.<br /><searchLink fieldCode="AU" term="%22Boursin+F%22">Boursin F</searchLink>; UMR 1282 ISP, Team BioMAP, University of Tours - INRAE, F-37200 Tours, France.<br /><searchLink fieldCode="AU" term="%22Dupeyrol+G%22">Dupeyrol G</searchLink>; UMR 1282 ISP, Team BioMAP, University of Tours - INRAE, F-37200 Tours, France.<br /><searchLink fieldCode="AU" term="%22André+V%22">André V</searchLink>; Pharmacy Department, Tours University Hospital, F-37200, France.<br /><searchLink fieldCode="AU" term="%22Velge+Roussel+F%22">Velge Roussel F</searchLink>; UPR 4301 CBM, CNRS, NMNS department, University of Tours, F-37200 Tours, France.<br /><searchLink fieldCode="AU" term="%22Denevault-Sabourin+C%22">Denevault-Sabourin C</searchLink>; UMR 1100, CEPR, Team Proteolytic enzymes and their pharmacological targeting in lung diseases, University of Tours, INSERM, F-37032 Tours, France.<br /><searchLink fieldCode="AU" term="%22Aubrey+N%22">Aubrey N</searchLink>; UMR 1282 ISP, Team BioMAP, University of Tours - INRAE, F-37200 Tours, France.<br /><searchLink fieldCode="AU" term="%22Allard-Vannier+E%22">Allard-Vannier E</searchLink>; UPR 4301 CBM, CNRS, NMNS department, University of Tours, F-37200 Tours, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229317982%22">European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</searchLink> [Eur J Pharm Sci] 2026 Jun 01; Vol. 221, pp. 107536. <i>Date of Electronic Publication: </i>2026 Apr 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+B%2EV%22">Elsevier Science B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9317982 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0720 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209280987%22">09280987 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Pharm Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42009233 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejps.2026.107536 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 107536 Titles: – TitleFull: Hospital in-use evaluation of the physical, chemical and affinity stability of the antibody-drug conjugate trastuzumab deruxtecan (Enhertu®). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Douez E – PersonEntity: Name: NameFull: Joubert N – PersonEntity: Name: NameFull: Gabant G – PersonEntity: Name: NameFull: Vidy E – PersonEntity: Name: NameFull: Auvert E – PersonEntity: Name: NameFull: Boursin F – PersonEntity: Name: NameFull: Dupeyrol G – PersonEntity: Name: NameFull: André V – PersonEntity: Name: NameFull: Velge Roussel F – PersonEntity: Name: NameFull: Denevault-Sabourin C – PersonEntity: Name: NameFull: Aubrey N – PersonEntity: Name: NameFull: Allard-Vannier E IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0720 Numbering: – Type: volume Value: 221 Titles: – TitleFull: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences Type: main |
| ResultId | 1 |